RD
Riya Das Pal
About Riya Das Pal
Data last updated:
Riya Das Pal is a Director at Zeonova Lifesciences Private Limited (since 2024) and Director at Mohitam Garments Private Limited (since 2018). The companies operate in Pharma and Textile. The largest current company by reported revenue is Zeonova Lifesciences Private Limited at ₹77.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Jan 2024 | 2024 | ₹77.3 Lakh (FY 2025) | Active | |
| Director | 22 May 2018 | 2018 | Active |
Board colleagues of Riya Das Pal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Joydip Jana | 10450602 | Zeonova Lifesciences Private Limited | Director |
| Nabanita Sinha | 10450603 | Zeonova Lifesciences Private Limited | Director |
| Sampa Singha | 10450604 | Zeonova Lifesciences Private Limited | Director |
| Brahmarshi Panigrahi | 08139890 | Mohitam Garments Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Riya Das Pal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Riya Das Pal
Riya Das Pal currently holds 2 directorships: Zeonova Lifesciences Private Limited (Director, since 15 Jan 2024, revenue ₹77.3 Lakh (FY 2025)); Mohitam Garments Private Limited (Director, since 22 May 2018).
Riya Das Pal was first appointed on 22 May 2018 as Director at Mohitam Garments Private Limited. The most recent appointment on record is 15 Jan 2024 at Zeonova Lifesciences Private Limited.
The current boards of Riya Das Pal's companies include Joydip Jana (Zeonova Lifesciences Private Limited), Nabanita Sinha (Zeonova Lifesciences Private Limited), Sampa Singha (Zeonova Lifesciences Private Limited), Brahmarshi Panigrahi (Mohitam Garments Private Limited).